cefixime has been researched along with Adverse Drug Event in 1 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horumpende, PG | 1 |
| Sonda, TB | 1 |
| van Zwetselaar, M | 1 |
| Antony, ML | 1 |
| Tenu, FF | 1 |
| Mwanziva, CE | 1 |
| Shao, ER | 1 |
| Mshana, SE | 1 |
| Mmbaga, BT | 1 |
| Chilongola, JO | 1 |
1 other study available for cefixime and Adverse Drug Event
| Article | Year |
|---|---|
Prescription and non-prescription antibiotic dispensing practices in part I and part II pharmacies in Moshi Municipality, Kilimanjaro Region in Tanzania: A simulated clients approach.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Community Pharmacy Services; Cross-Sectional Studies; | 2018 |